HIGHLIGHTS   |  April 24, 2020   FDA Approves Pemigatinib for Advanced Cholangiocarcinoma This is the first FDA approval for this patient population. Read more ADVERTISEMENT   Overall Survival Rates Differ Among Patients with Cancer of Different Races and Ethnicities A recent study examined the differences in stage of leading cancer types at diagnosis, treatment and overall survival of patients according to different races and ethnicities. Read more   In Case You Missed It

Researchers Outline Recommendations for Testing Patients with Lung Cancer for COVID-19 Researchers outlined recommendations for testing patients with lung cancer for COVID-19, given their specific cumulative risk factors for COVID-19 complications. Read more